Renub Research has recently published a report named "Asia Breast Cancer Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2028," providing a detailed industry analysis that consists of market share insights. Furthermore, the report encompasses a study of competitors and regions and the recent growth in the Asia Breast Cancer Screening Market.

1. Asia Breast Cancer Screening
Market is expected to reach
US$ 275.6 Million by 2028
Base Year: 2022
Market Research & Advisory

2. 2
2
Asia Breast Cancer Screening Market
Renub Research has recently published a report named "Asia Breast Cancer Screening Market: Global Industry
Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2028," providing a detailed industry analysis that
consists of market share insights. Furthermore, the report encompasses a study of competitors and regions and the
recent growth in the Asia Breast Cancer Screening Market.
Expert Insights: Ask Analyst or Download Full Report with TOC & Figures: https://www.renub.com/asia-
breast-cancer-screening-market-forecast-mammography-mri-and-ultrasound-1122-p.php
Asia breast cancer screening market is expected to grow significantly between 2022 and 2028, at a CAGR of
4.14%.Breast cancer (BC) is the most frequently diagnosed malignancy and the leading cause of death for women.
The number of new cases and deaths worldwide was estimated to be 2.3 million and 684,996, respectively. Breast
Cancer, a major women’s health difficulty, has been gaining interest as its prevalence and mortality are growing,
making it the 5th main motive of most cancers mortality. Nearly 1/2 of the breast most cancers patients were
recognized in Asia.
2
https://www.renub.com

3. 3
3
Asia Breast Cancer Screening Market
Asian ladies are recognized with most breast cancers at a youth age than their Western women. The peak age for
breast cancer occurrence in Asian locations is generally among 40 and 50 years, whereas it's miles generally
among 60 and 70 years in Western countries. This disparity emphasizes the significance of taking local and
demographic factors into consideration while developing breast cancers prevention, screening, and remedy
techniques. Understanding these variations can assist tailor healthcare strategies to successfully cope with the
unique needs and demanding situations faced with the aid of exceptional populations in the fight against breast
most cancers.
Breast cancer consciousness is growing in Asia, way to public training campaigns, government tasks, and expanded
screening offerings. Screening offerings are becoming extra reachable because of authorities investments, the
enlargement of private healthcare providers, and the usage of telemedicine. Furthermore, the place is seeing an
increase in demand for early breast most cancers detection, which could cause extra powerful treatment and a
better analysis.
3
https://www.renub.com

4. 4
4
Asia Breast Cancer Screening Market
Increasing research activities are likely to boost the Asia-Pacific breast
cancer screening market. In Japan, for example, a study called "Novel
combination of serum microRNA for detecting breast cancer in the early
stage" was carried out. Furthermore, because cancer is one of the
leading causes of death in Japan, the Japanese government has
initiated cancer control programs. Municipalities throughout the country
run cancer screening programs with government funding.
Increasing research activities are in all likelihood to boost the Asia-
Pacific breast cancer screening market. In Japan, for instance, a study
called "Novel aggregate of serum microRNA for detecting breast cancers
in the early level“ was carried out. Furthermore, due to one of the main
causes of demise in Japan, the Japanese government has initiated
cancer manage packages. Municipalities throughout the country run
most cancers screening programs with authority’s investment.
4
https://www.renub.com

5. 5
5
Asia Breast Cancer Screening Market
China is poised to make widespread advancements in Asia's breast most
cancers screening market.
Healthcare professionals and the general public are becoming more aware of
breast cancer because of its rising prevalence, fuelled by aging populations and
lifestyle changes. The need for early detection greatly enhances treatment
outcomes as more screening services become available. A large and well-
functioning healthcare system, a steadfast government commitment to public
health, and a developing technological infrastructure are just a few of China's
advantages. These factors make it possible to create and implement cutting-edge
screening and prevention programs. China is in a strong position to significantly
impact breast cancer prevention and treatment thanks to its resources and resolve.
Request a free sample copy of the report: https://www.renub.com/request-
sample-page.php?gturl=asia-breast-cancer-screening-market-forecast-
mammography-mri-and-ultrasound-1122-p.php
5
https://www.renub.com

6. 6
6
Asia Breast Cancer Screening Market
Asia Breast Cancer Screening Market- Breast cancer screening markets have been examined in seven
Asian countries.
1. China 2. India 3. Japan 4. Korea
5. Singapore 6. Thailand 7. Malaysia
India is surfacing as the augmenting market in the Asia Breast Cancer Mammography screening industry.
India has a high prevalence of breast cancer, and the incidence is rising due to aging populations, altered lifestyles,
and genetics. About 1,62,468 new cases and 87,090 fatalities are anticipated in 2022, making it responsible for 25%
of all cancers in women. According to GLOBOCON predictions, breast cancer cases will increase by 70% between
2020 and 2040.Public education campaigns, government initiatives, and improved screening services' availability,
including telemedicine, are driving the country's growing awareness of breast cancer. For better treatment
outcomes, early detection is desired. Government policies that are helpful, such as funding for screening initiatives
and tax exemptions on screening tools, help India's healthcare system deal with this problem.
6
https://www.renub.com

7. 7
7
Asia Breast Cancer Screening Market
Mammography Screening - The Asia breast cancer screening markets in seven countries.
1. China 2. India 3. Japan 4. Korea
5. Singapore 6. Thailand 7. Malaysia
The share of China in the Asia Breast Cancer MRI Screening market is anticipated to rise significantly.
China's substantial investment in healthcare, particularly in advanced medical technologies like MRI machines for
breast cancer screening, coupled with efforts to expand healthcare coverage, raise awareness, and benefit from
rapid advancements in medical technology, supported by strong government backing and increased healthcare
expenditure, are all factors contributing to the expected substantial growth of China's market share in the Asian
Breast Cancer MRI Screening sector.
MRI Screening - Research has been done on the Asia breast cancer screening markets in seven nations.
1. China 2. India 3. Japan 4. Korea
5. Singapore 6. Thailand 7. Malaysia
7
https://www.renub.com

8. 8
8
Asia Breast Cancer Screening Market
China will likely dominate the Asia market for breast cancer ultrasound screening.
The country's healthcare industry has recently seen impressive advancements in ultrasound technology, improving
the accuracy and effectiveness of breast cancer diagnosis. The demand for ultrasound screening services has
increased dramatically across China as people become more aware of the critical importance of early detection and
screening. The government's programs to improve healthcare access, especially in rural areas, have significantly
contributed to the sector's explosive growth. Collaborations between experts in the medical field, academic
institutions, and powerful corporations have also been essential for fostering innovation and advancing the adoption
of sophisticated ultrasound screening technologies.
Ultrasound Screening - A study of the Asia breast cancer screening markets in seven countries has been
conducted.
1. China 2. India 3. Japan 4. Korea
5. Singapore 6. Thailand 7. Malaysia
8
https://www.renub.com

9. 9
9
Asia Breast Cancer Screening Market
Competitive Landscape
Asia Breast Cancer Screening market consists of companies like AstraZeneca, Hologic Corporation, Becton,
Siemens AG, Roche Diagnostics, Quest Diagnostics, and Cardinal Health.
Company Insights:
• Overview • Recent Development • Sales Analysis
Companies Covered in the Report:
1. AstraZeneca 2. Hologic Corporation 3. Becton
4. Siemens AG 5. Roche Diagnostics 6. Quest Diagnostics
7. Cardinal Health
9
https://www.renub.com

10. S
O U T
A U
B
10
https://www.renub.com
Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in
Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy,
organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000
syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to
EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings
and perspectives across a wide range of markets.
Media Contact:
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Address: 225 Kristie Ln, Roswell, GA 30076
Email: info@renub.com
LinkedIn: https://linkedin.com/company/renub-research